RUA Life Sciences (GB:RUA) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
RUA Life Sciences has strategically expanded its contract manufacturing business with the acquisition of Analytic Biosurgical Solutions SAS (Abiss), a company specializing in implantable medical devices, for €80,000. Abiss, which was not in liquidation despite its parent company’s insolvency, has a strong track record with innovative surgical implants, owns intellectual property rights, and has a growing contract manufacture business. This acquisition is set to bolster RUA’s medium-term growth targets and complements its existing customer relationships and reputation for quality in the medical device sector.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.
